Comparison of Metabolic Dysfunction-Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin-Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices.

IF 2.7 4区 医学 Q3 GERIATRICS & GERONTOLOGY
Makoto Miyabayashi, Masaya Koshizaka, Mayumi Shoji, Hiyori Kaneko, Kazuto Aono, Hisaya Kato, Tetta Sato, Takuro Horikoshi, Mai Ishikawa, Akiko Sekiguchi, Sei-Ichiro Motegi, Shinji Tsukamoto, Akira Taniguchi, Yukiko Shoda, Toru Yoshimura, Junji Kawashima, Kayo Yoshinaga, Hironori Nakagami, Yoichi Takami, Ken Sugimoto, Kunihiko Hashimoto, Naoki Okubo, Masato Ohara, Takashi Yoshida, Asako Kogure, Daisuke Suzuki, Masafumi Kuzuya, Kazuhisa Watanabe, Minoru Takemoto, Junko Oshima, Yoshiro Maezawa, Koutaro Yokote
{"title":"Comparison of Metabolic Dysfunction-Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin-Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices.","authors":"Makoto Miyabayashi, Masaya Koshizaka, Mayumi Shoji, Hiyori Kaneko, Kazuto Aono, Hisaya Kato, Tetta Sato, Takuro Horikoshi, Mai Ishikawa, Akiko Sekiguchi, Sei-Ichiro Motegi, Shinji Tsukamoto, Akira Taniguchi, Yukiko Shoda, Toru Yoshimura, Junji Kawashima, Kayo Yoshinaga, Hironori Nakagami, Yoichi Takami, Ken Sugimoto, Kunihiko Hashimoto, Naoki Okubo, Masato Ohara, Takashi Yoshida, Asako Kogure, Daisuke Suzuki, Masafumi Kuzuya, Kazuhisa Watanabe, Minoru Takemoto, Junko Oshima, Yoshiro Maezawa, Koutaro Yokote","doi":"10.1111/ggi.70866","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study compared metabolic dysfunction-associated steatotic liver disease (MASLD) in individuals with Werner syndrome (WS) and individuals with insulin-resistant type 2 diabetes (T2D). It also examined the association with imaging findings of MASLD in individuals with WS, clarified the characteristics of MASLD that accompany WS, and identified useful indices for its diagnosis in addition to imaging.</p><p><strong>Methods: </strong>Three hepatic steatosis and two hepatic fibrosis indices in 48 individuals enrolled in the Japanese Werner Syndrome Registry were compared with those in 101 Japanese individuals with insulin-resistant T2D from another clinical study. In individuals with WS, the liver/spleen ratio (L/S ratio) was calculated from computed tomography (CT) images, and its associations with each index were examined. Statistical analyses were performed using the Welch test and pairwise comparisons.</p><p><strong>Results: </strong>Individuals with WS had lower hepatic steatosis and fibrosis index values than those with insulin-resistant T2D. The mean L/S ratio calculated from CT images was 1.05 ± 0.24 in individuals with WS. The L/S ratio, which is one of the indicators for diagnosing MASLD, was < 0.9 in 5 of 20 cases (25%). Among the various indices in individuals with WS, only the hepatic steatosis index (HSI) was correlated with the L/S ratio (r = -0.863, p = 0.0003).</p><p><strong>Conclusions: </strong>The prevalence of MASLD is lower in individuals with WS than in those with insulin-resistant T2D. The HSI was associated with the L/S ratio in individuals with WS, suggesting that HSI may reflect hepatic steatosis-related changes in this population. Further studies in larger cohorts are needed to validate these findings.</p><p><strong>Trial registration: </strong>The study was registered at the UMIN Clinical Trial Registry (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034058) on November 3, 2017 (ID: UMIN000029812).</p>","PeriodicalId":12546,"journal":{"name":"Geriatrics & Gerontology International","volume":"26 10","pages":"e70866"},"PeriodicalIF":2.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13662814/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrics & Gerontology International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ggi.70866","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study compared metabolic dysfunction-associated steatotic liver disease (MASLD) in individuals with Werner syndrome (WS) and individuals with insulin-resistant type 2 diabetes (T2D). It also examined the association with imaging findings of MASLD in individuals with WS, clarified the characteristics of MASLD that accompany WS, and identified useful indices for its diagnosis in addition to imaging.

Methods: Three hepatic steatosis and two hepatic fibrosis indices in 48 individuals enrolled in the Japanese Werner Syndrome Registry were compared with those in 101 Japanese individuals with insulin-resistant T2D from another clinical study. In individuals with WS, the liver/spleen ratio (L/S ratio) was calculated from computed tomography (CT) images, and its associations with each index were examined. Statistical analyses were performed using the Welch test and pairwise comparisons.

Results: Individuals with WS had lower hepatic steatosis and fibrosis index values than those with insulin-resistant T2D. The mean L/S ratio calculated from CT images was 1.05 ± 0.24 in individuals with WS. The L/S ratio, which is one of the indicators for diagnosing MASLD, was < 0.9 in 5 of 20 cases (25%). Among the various indices in individuals with WS, only the hepatic steatosis index (HSI) was correlated with the L/S ratio (r = -0.863, p = 0.0003).

Conclusions: The prevalence of MASLD is lower in individuals with WS than in those with insulin-resistant T2D. The HSI was associated with the L/S ratio in individuals with WS, suggesting that HSI may reflect hepatic steatosis-related changes in this population. Further studies in larger cohorts are needed to validate these findings.

Trial registration: The study was registered at the UMIN Clinical Trial Registry (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034058) on November 3, 2017 (ID: UMIN000029812).

维尔纳综合征和胰岛素抵抗型2型糖尿病患者代谢功能障碍相关脂肪变性肝病的比较:肝脂肪变性和纤维化指标
目的:本研究比较了Werner综合征(WS)患者和胰岛素抵抗型2型糖尿病(T2D)患者的代谢功能障碍相关脂肪变性肝病(MASLD)。该研究还研究了WS患者MASLD与影像学表现的关系,阐明了伴随WS的MASLD的特征,并确定了除影像学外诊断的有用指标。方法:将日本Werner综合征登记处登记的48例患者的3项肝脂肪变性和2项肝纤维化指标与另一项临床研究中101例日本胰岛素抵抗型T2D患者的指标进行比较。在WS患者中,通过计算机断层扫描(CT)图像计算肝/脾比值(L/S ratio),并检查其与各指标的相关性。采用Welch检验和两两比较进行统计分析。结果:WS患者的肝脂肪变性和纤维化指数低于胰岛素抵抗型T2D患者。WS患者CT图像的平均L/S比为1.05±0.24。诊断MASLD的指标之一L/S比值为:结论:WS患者MASLD患病率低于胰岛素抵抗型T2D患者。HSI与WS患者的L/S比值相关,提示HSI可能反映了该人群中与肝脂肪变性相关的变化。需要在更大的队列中进行进一步的研究来验证这些发现。试验注册:该研究已于2017年11月3日在UMIN临床试验注册中心(https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034058)注册(ID: UMIN000029812)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.50
自引率
6.10%
发文量
189
审稿时长
4-8 weeks
期刊介绍: Geriatrics & Gerontology International is the official Journal of the Japan Geriatrics Society, reflecting the growing importance of the subject area in developed economies and their particular significance to a country like Japan with a large aging population. Geriatrics & Gerontology International is now an international publication with contributions from around the world and published four times per year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书